The biotechnology sector views itself as a potential defense partner, already offering solutions applicable on the front lines. However, industry representatives note that clearer strategic direction from the state and consistent dialogue with defense institutions are needed to achieve a breakthrough.
Gražina Mykolaitytė – Nielsen, CEO of VUGENE, states, “Biotechnology is becoming a strategic pillar of national security. Health, biological resilience, cognitive function, and rapid innovation cycles are becoming just as vital as traditional weaponry – a view NATO is already clearly adopting.”
Key areas where biotechnology is critical for defense include antimicrobial resistance in conflict zones, frontline mobile laboratories and diagnostics, vaccine production in crisis conditions, biological data protection, and supply chain resilience.
Mykolaitytė – Nielsen highlights mobile laboratories and remote diagnostics as practical solutions already in use. These tools allow for operations in conflict zones while ensuring data is safely analyzed beyond borders. She adds that in some areas, scientific innovation is outpacing defense adaptation – specifically regarding the parallels between biological data protection and cybersecurity.
“Developing antiviral or antibacterial countermeasures requires DNA analysis, yet countries are reluctant to share such data due to security concerns. This creates a significant opportunity for solutions ranging from secure encryption to the application of quantum technologies for biological data,” says Mykolaitytė – Nielsen.
VUGENE is dedicated to developing innovative biological data analysis solutions, particularly in the realm of secure mobile diagnostics. These tools are critical for frontline resilience and timely threat detection.
Read full article: Link
Published by: Verslo žinios on January 12, 2026
Cover photo credits: Andrej Vasilenko
